Onboarding overhaul at a health-tech startup increased activation by 28%

Design · 5 min read

Early onboarding forced long-form consent and a multi-page profile step before users could experience the product. Many churned during onboarding, citing fatigue and unclear benefits. Researchers segmented churn by arrival channel and found that clinically-referred users wanted reassurance, while direct-to-consumer users wanted to try core features quickly.

The redesign split onboarding into three modular stages: quick trial activation (core experience in under two minutes), progressive consent (meaningful chunks aligned with data use), and optional clinician profile linking for those referred. Microcopy focused on outcomes, and first-run experiences highlighted an immediate, tangible metric so users could see progress in the first session.

Post-launch metrics showed a 28% increase in 7-day activation and a 19% lift in 30-day retention among direct-to-consumer cohorts. Clinician-referred users reported higher satisfaction because the app made clinician integration explicit and optional rather than mandatory.

The case demonstrates that onboarding should be tailored to acquisition channels and that separating consent and experience—while maintaining transparency—can reduce friction without compromising compliance.